XWELL, Inc. (XWEL)
1.22
+0.08
(+7.02%)
USD |
NASDAQ |
Apr 24, 16:00
1.21
-0.01
(-0.82%)
After-Hours: 20:00
XWELL EPS Diluted (Quarterly) : -3.036 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| FONAR Corp. | 0.3058 |
| Interpace Biosciences, Inc. | 0.8178 |
| Thermo Fisher Scientific, Inc. | 4.43 |
| Hypha Labs, Inc. | -0.0034 |
| Veracyte, Inc. | 0.5056 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.59M |
| Revenue (Quarterly) | 7.154M |
| Total Expenses (Quarterly) | 18.77M |
| Enterprise Value | 29.22M |
| Gross Profit Margin (Quarterly) | 36.79% |
| Profit Margin (Quarterly) | -162.0% |
| Earnings Yield | -389.4% |
| Normalized Earnings Yield | -364.96 |